Specification of haematopoietic stem cell fate via modulation of mitochondrial activity
- PMID: 27731316
- PMCID: PMC5064016
- DOI: 10.1038/ncomms13125
Specification of haematopoietic stem cell fate via modulation of mitochondrial activity
Abstract
Haematopoietic stem cells (HSCs) differ from their committed progeny by relying primarily on anaerobic glycolysis rather than mitochondrial oxidative phosphorylation for energy production. However, whether this change in the metabolic program is the cause or the consequence of the unique function of HSCs remains unknown. Here we show that enforced modulation of energy metabolism impacts HSC self-renewal. Lowering the mitochondrial activity of HSCs by chemically uncoupling the electron transport chain drives self-renewal under culture conditions that normally induce rapid differentiation. We demonstrate that this metabolic specification of HSC fate occurs through the reversible decrease of mitochondrial mass by autophagy. Our data thus reveal a causal relationship between mitochondrial metabolism and fate choice of HSCs and also provide a valuable tool to expand HSCs outside of their native bone marrow niches.
Conflict of interest statement
N.V., M.P.L., J.A., O.N., M.G. are authors on a patent entitled ‘Methods compounds useful in hematopoietic stem cell medicine' patent number P1828EP00 (2016). The remaining authors declare no competing financial interests.
Figures
References
-
- Suda T., Takubo K. & Semenza G. L. Metabolic regulation of hematopoietic stem cells in the hypoxic niche. Cell Stem Cell 9, 298–310 (2011). - PubMed
-
- Hofmeister C. C., Zhang J., Knight K. L., Le P. & Stiff P. J. Ex vivo expansion of umbilical cord blood stem cells for transplantation: growing knowledge from the hematopoietic niche. Bone Marrow Transplant 39, 11–23 (2007). - PubMed
-
- Wagner J. E. et al.. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 100, 1611–1618 (2002). - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
